Nurse Practitioner in Laurel Springs, NJ Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Mrs. Victoria Lyn Bellmore, APN, C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 16 Roosevelt Dr, Laurel Springs, NJ 08021 Phone: 800-213-2266 Fax: 856-232-8260 |
Barbara Vassallo, APN Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 16 Roosevelt Drive, Laurel Springs, NJ 08021 Phone: 856-232-6058 Fax: 856-232-8260 |
Catherine A Menewisch, CRNP Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 16 Roosevelt Drive, Laurel Springs, NJ 08021 Phone: 856-232-6058 Fax: 856-232-8260 |
Jenna Connor, Nurse Practitioner - Gerontology Medicare: Medicare Enrolled Practice Location: 1385 Chews Landing Rd, Laurel Springs, NJ 08021 Phone: 800-427-1902 |
Marisa Cinalli, MSN,RN,APN-C Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 1405 Chews Landing Rd, Laurel Springs, NJ 08021 Phone: 856-227-6575 Fax: 856-374-9495 |
Mrs. Alyssa P Taylor, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1385 Chews Landing Rd, Laurel Springs, NJ 08021 Phone: 866-380-5874 |
Theresa Soutar, R.N. APN-C Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 1405 Chews Landing Rd, Laurel Springs, NJ 08021 Phone: 856-227-6575 Fax: 856-374-9495 |
News Archive
Thiazolidinedione (TZD) class of anti-diabetic drugs may be a potential targeted therapy for myeloma patients
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
Occasional medicine users not getting the full benefits of their medicines
Survey findings released for Be Medicinewise Week (22-28 August) have revealed that occasional users of medicines—including prescription, over-the-counter, and alternative or complementary forms of medicines—are potentially not getting the full benefits from their medicines, compared to people who take medicines more often.
FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
People with rheumatoid arthritis less likely to benefit from hepatitis B vaccine
The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with rheumatoid arthritis (RA) are less likely to be protected by hepatitis B vaccination than the general population.
› Verified 3 days ago